Global Infectious Disease Diagnostic Testing Market Growth (Status and Outlook) 2026-2032
The global Infectious Disease Diagnostic Testing market size is predicted to grow from US$ 25377 million in 2025 to US$ 34910 million in 2032; it is expected to grow at a CAGR of 4.8% from 2026 to 2032.
Infectious Disease Diagnostic Testing refers to a product and method system used to detect infections caused by viruses, bacteria, fungi, parasites, mycoplasma, chlamydia, and other pathogens. It uses in-vitro diagnostic reagents, testing instruments, automated platforms, point-of-care devices, quality-control systems, and informatics tools to analyze human samples such as blood, respiratory specimens, urine, stool, cerebrospinal fluid, secretions, and tissue. Targets may include pathogen nucleic acids, antigens, antibodies, toxins, resistance genes, culture results, or host immune-response markers. The field covers molecular testing, immunoassays, microbiological culture, mass spectrometry identification, antimicrobial susceptibility testing, multiplex panels, sequencing, and POCT rapid testing. It serves clinical diagnosis, medication guidance, infection control, disease screening, public health surveillance, border quarantine, and epidemic early warning, forming a critical capability for early detection, early diagnosis, early treatment, and precise prevention.The average gross profit margin of this product is 53%.
Infectious disease diagnostic testing is evolving from single-outbreak emergency testing into a long-term demand-driven market supported by clinical care, public health surveillance, infection control, and antimicrobial stewardship. Respiratory infections, blood-borne diseases, gastrointestinal infections, sexually transmitted infections, tuberculosis, antimicrobial-resistant pathogens, and emerging infectious diseases all require healthcare and public health systems to build rapid, accurate, and traceable testing capabilities. Governments continue to strengthen infectious disease surveillance and early warning, laboratory capacity, medical-public health coordination, and interconnection of testing data, providing a stable institutional environment for the industry. Corporate annual reports show that global diagnostic leaders are continuously investing in molecular diagnostics, rapid testing, microbiology, and multiplex panels, driving the industry from single assays toward platform-based, automated, and data-driven testing.The industry faces multiple challenges, including demand volatility, pricing pressure, regulatory access, technology iteration, quality consistency, and product homogenization. After the pandemic, demand for some single-pathogen tests has returned to a more normalized level, requiring companies to shift from short-cycle outbreak-driven products toward comprehensive portfolios covering multiple diseases, sample types, and clinical scenarios. Molecular testing requires high sensitivity, specificity, contamination control, and robust laboratory workflows. Immunoassays depend on antigen and antibody quality, lot-to-lot consistency, and signal stability. Microbiological testing is strongly affected by sample processing, culture identification, antimicrobial susceptibility interpretation, and database accumulation. At the same time, public health demand can be sudden and seasonal, requiring stronger resilience in capacity planning, inventory management, raw-material supply, and channel response. Future competition will shift from price to clinical value, platform compatibility, test-menu completeness, and supply-chain security.Downstream demand is moving from ?whether a test is available? to ?whether testing can be faster, more accurate, and more closely linked to clinical decisions.? Emergency departments, infectious disease departments, respiratory departments, intensive care units, clinical laboratories, and infection-control teams in large hospitals need rapid etiological testing, resistance monitoring, and multiplex panels to shorten diagnostic time, optimize medication pathways, and reduce nosocomial transmission risk. Primary healthcare institutions need rapid testing solutions that are easy to operate, short in turnaround time, and suitable for initial screening and triage. Independent clinical laboratories focus on batch testing, automated workflows, and cost efficiency, while public health systems value pathogen-spectrum monitoring, regional epidemic assessment, and data-reporting capability. As medical-public health coordination, tiered diagnosis, and digital surveillance systems improve, infectious disease diagnostic testing will become a key node linking clinical treatment, hospital operations, and public health governance.
LPI (LP Information)' newest research report, the ?Infectious Disease Diagnostic Testing Industry Forecast? looks at past sales and reviews total world Infectious Disease Diagnostic Testing sales in 2025, providing a comprehensive analysis by region and market sector of projected Infectious Disease Diagnostic Testing sales for 2026 through 2032. With Infectious Disease Diagnostic Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Infectious Disease Diagnostic Testing industry.
This Insight Report provides a comprehensive analysis of the global Infectious Disease Diagnostic Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Infectious Disease Diagnostic Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Infectious Disease Diagnostic Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infectious Disease Diagnostic Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infectious Disease Diagnostic Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Infectious Disease Diagnostic Testing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Infectious Disease Diagnostic Testing refers to a product and method system used to detect infections caused by viruses, bacteria, fungi, parasites, mycoplasma, chlamydia, and other pathogens. It uses in-vitro diagnostic reagents, testing instruments, automated platforms, point-of-care devices, quality-control systems, and informatics tools to analyze human samples such as blood, respiratory specimens, urine, stool, cerebrospinal fluid, secretions, and tissue. Targets may include pathogen nucleic acids, antigens, antibodies, toxins, resistance genes, culture results, or host immune-response markers. The field covers molecular testing, immunoassays, microbiological culture, mass spectrometry identification, antimicrobial susceptibility testing, multiplex panels, sequencing, and POCT rapid testing. It serves clinical diagnosis, medication guidance, infection control, disease screening, public health surveillance, border quarantine, and epidemic early warning, forming a critical capability for early detection, early diagnosis, early treatment, and precise prevention.The average gross profit margin of this product is 53%.
Infectious disease diagnostic testing is evolving from single-outbreak emergency testing into a long-term demand-driven market supported by clinical care, public health surveillance, infection control, and antimicrobial stewardship. Respiratory infections, blood-borne diseases, gastrointestinal infections, sexually transmitted infections, tuberculosis, antimicrobial-resistant pathogens, and emerging infectious diseases all require healthcare and public health systems to build rapid, accurate, and traceable testing capabilities. Governments continue to strengthen infectious disease surveillance and early warning, laboratory capacity, medical-public health coordination, and interconnection of testing data, providing a stable institutional environment for the industry. Corporate annual reports show that global diagnostic leaders are continuously investing in molecular diagnostics, rapid testing, microbiology, and multiplex panels, driving the industry from single assays toward platform-based, automated, and data-driven testing.The industry faces multiple challenges, including demand volatility, pricing pressure, regulatory access, technology iteration, quality consistency, and product homogenization. After the pandemic, demand for some single-pathogen tests has returned to a more normalized level, requiring companies to shift from short-cycle outbreak-driven products toward comprehensive portfolios covering multiple diseases, sample types, and clinical scenarios. Molecular testing requires high sensitivity, specificity, contamination control, and robust laboratory workflows. Immunoassays depend on antigen and antibody quality, lot-to-lot consistency, and signal stability. Microbiological testing is strongly affected by sample processing, culture identification, antimicrobial susceptibility interpretation, and database accumulation. At the same time, public health demand can be sudden and seasonal, requiring stronger resilience in capacity planning, inventory management, raw-material supply, and channel response. Future competition will shift from price to clinical value, platform compatibility, test-menu completeness, and supply-chain security.Downstream demand is moving from ?whether a test is available? to ?whether testing can be faster, more accurate, and more closely linked to clinical decisions.? Emergency departments, infectious disease departments, respiratory departments, intensive care units, clinical laboratories, and infection-control teams in large hospitals need rapid etiological testing, resistance monitoring, and multiplex panels to shorten diagnostic time, optimize medication pathways, and reduce nosocomial transmission risk. Primary healthcare institutions need rapid testing solutions that are easy to operate, short in turnaround time, and suitable for initial screening and triage. Independent clinical laboratories focus on batch testing, automated workflows, and cost efficiency, while public health systems value pathogen-spectrum monitoring, regional epidemic assessment, and data-reporting capability. As medical-public health coordination, tiered diagnosis, and digital surveillance systems improve, infectious disease diagnostic testing will become a key node linking clinical treatment, hospital operations, and public health governance.
LPI (LP Information)' newest research report, the ?Infectious Disease Diagnostic Testing Industry Forecast? looks at past sales and reviews total world Infectious Disease Diagnostic Testing sales in 2025, providing a comprehensive analysis by region and market sector of projected Infectious Disease Diagnostic Testing sales for 2026 through 2032. With Infectious Disease Diagnostic Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Infectious Disease Diagnostic Testing industry.
This Insight Report provides a comprehensive analysis of the global Infectious Disease Diagnostic Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Infectious Disease Diagnostic Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Infectious Disease Diagnostic Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infectious Disease Diagnostic Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infectious Disease Diagnostic Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Infectious Disease Diagnostic Testing market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Blood Sample
- Respiratory Sample
- Urine Sample
- Other
- Molecular Diagnostics
- Immunodiagnostics
- Culture & AST
- POCT Rapid Tests
- Other
- Respiratory Infections
- Hepatitis & Blood-borne
- Sexually Transmitted Infections
- Gastrointestinal Infections
- Other
- Public Hospitals
- Third-party Independent Laboratory
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- BD
- Danaher
- Abbott
- bioM?rieux
- Hologic
- Thermo Fisher Scientific
- Roche
- DiaSorin
- QuidelOrtho
- Siemens Healthineers
- Qiagen
- Bio-Rad
- Wondfo Biotech
- Autobio
- Daan Gene
- Innovita
- Hybribio
- BioPerfectus
- Sansure
- Liferiver
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Infectious Disease Diagnostic Testing Market Size (2021-2032)
2.1.2 Infectious Disease Diagnostic Testing Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Infectious Disease Diagnostic Testing by Country/Region (2021, 2025 & 2032)
2.2 Infectious Disease Diagnostic Testing Segment by Type
2.2.1 Blood Sample
2.2.2 Respiratory Sample
2.2.3 Urine Sample
2.2.4 Other
2.2.5 Infectious Disease Diagnostic Testing Market Size by Type
2.2.5.1 Infectious Disease Diagnostic Testing Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Infectious Disease Diagnostic Testing Market Size Market Share by Type (2021-2026)
2.3 Infectious Disease Diagnostic Testing Segment by Technology
2.3.1 Molecular Diagnostics
2.3.2 Immunodiagnostics
2.3.3 Culture & AST
2.3.4 POCT Rapid Tests
2.3.5 Other
2.3.6 Infectious Disease Diagnostic Testing Market Size by Technology
2.3.6.1 Infectious Disease Diagnostic Testing Market Size CAGR by Technology (2021 VS 2025 VS 2032)
2.3.6.2 Global Infectious Disease Diagnostic Testing Market Size Market Share by Technology (2021-2026)
2.4 Infectious Disease Diagnostic Testing Segment by Test Item
2.4.1 Respiratory Infections
2.4.2 Hepatitis & Blood-borne
2.4.3 Sexually Transmitted Infections
2.4.4 Gastrointestinal Infections
2.4.5 Other
2.4.6 Infectious Disease Diagnostic Testing Market Size by Test Item
2.4.6.1 Infectious Disease Diagnostic Testing Market Size CAGR by Test Item (2021 VS 2025 VS 2032)
2.4.6.2 Global Infectious Disease Diagnostic Testing Market Size Market Share by Test Item (2021-2026)
2.5 Infectious Disease Diagnostic Testing Segment by Application
2.5.1 Public Hospitals
2.5.2 Third-party Independent Laboratory
2.5.3 Other
2.5.4 Infectious Disease Diagnostic Testing Market Size by Application
2.5.4.1 Infectious Disease Diagnostic Testing Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Infectious Disease Diagnostic Testing Market Size Market Share by Application (2021-2026)
3 INFECTIOUS DISEASE DIAGNOSTIC TESTING MARKET SIZE BY PLAYER
3.1 Infectious Disease Diagnostic Testing Market Size Market Share by Player
3.1.1 Global Infectious Disease Diagnostic Testing Revenue by Player (2021-2026)
3.1.2 Global Infectious Disease Diagnostic Testing Revenue Market Share by Player (2021-2026)
3.2 Global Infectious Disease Diagnostic Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 INFECTIOUS DISEASE DIAGNOSTIC TESTING BY REGION
4.1 Infectious Disease Diagnostic Testing Market Size by Region (2021-2026)
4.2 Global Infectious Disease Diagnostic Testing Annual Revenue by Country/Region (2021-2026)
4.3 Americas Infectious Disease Diagnostic Testing Market Size Growth (2021-2026)
4.4 APAC Infectious Disease Diagnostic Testing Market Size Growth (2021-2026)
4.5 Europe Infectious Disease Diagnostic Testing Market Size Growth (2021-2026)
4.6 Middle East & Africa Infectious Disease Diagnostic Testing Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Infectious Disease Diagnostic Testing Market Size by Country (2021-2026)
5.2 Americas Infectious Disease Diagnostic Testing Market Size by Type (2021-2026)
5.3 Americas Infectious Disease Diagnostic Testing Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Infectious Disease Diagnostic Testing Market Size by Region (2021-2026)
6.2 APAC Infectious Disease Diagnostic Testing Market Size by Type (2021-2026)
6.3 APAC Infectious Disease Diagnostic Testing Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Infectious Disease Diagnostic Testing Market Size by Country (2021-2026)
7.2 Europe Infectious Disease Diagnostic Testing Market Size by Type (2021-2026)
7.3 Europe Infectious Disease Diagnostic Testing Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Infectious Disease Diagnostic Testing by Region (2021-2026)
8.2 Middle East & Africa Infectious Disease Diagnostic Testing Market Size by Type (2021-2026)
8.3 Middle East & Africa Infectious Disease Diagnostic Testing Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL INFECTIOUS DISEASE DIAGNOSTIC TESTING MARKET FORECAST
10.1 Global Infectious Disease Diagnostic Testing Forecast by Region (2027-2032)
10.1.1 Global Infectious Disease Diagnostic Testing Forecast by Region (2027-2032)
10.1.2 Americas Infectious Disease Diagnostic Testing Forecast
10.1.3 APAC Infectious Disease Diagnostic Testing Forecast
10.1.4 Europe Infectious Disease Diagnostic Testing Forecast
10.1.5 Middle East & Africa Infectious Disease Diagnostic Testing Forecast
10.2 Americas Infectious Disease Diagnostic Testing Forecast by Country (2027-2032)
10.2.1 United States Market Infectious Disease Diagnostic Testing Forecast
10.2.2 Canada Market Infectious Disease Diagnostic Testing Forecast
10.2.3 Mexico Market Infectious Disease Diagnostic Testing Forecast
10.2.4 Brazil Market Infectious Disease Diagnostic Testing Forecast
10.3 APAC Infectious Disease Diagnostic Testing Forecast by Region (2027-2032)
10.3.1 China Infectious Disease Diagnostic Testing Market Forecast
10.3.2 Japan Market Infectious Disease Diagnostic Testing Forecast
10.3.3 Korea Market Infectious Disease Diagnostic Testing Forecast
10.3.4 Southeast Asia Market Infectious Disease Diagnostic Testing Forecast
10.3.5 India Market Infectious Disease Diagnostic Testing Forecast
10.3.6 Australia Market Infectious Disease Diagnostic Testing Forecast
10.4 Europe Infectious Disease Diagnostic Testing Forecast by Country (2027-2032)
10.4.1 Germany Market Infectious Disease Diagnostic Testing Forecast
10.4.2 France Market Infectious Disease Diagnostic Testing Forecast
10.4.3 UK Market Infectious Disease Diagnostic Testing Forecast
10.4.4 Italy Market Infectious Disease Diagnostic Testing Forecast
10.4.5 Russia Market Infectious Disease Diagnostic Testing Forecast
10.5 Middle East & Africa Infectious Disease Diagnostic Testing Forecast by Region (2027-2032)
10.5.1 Egypt Market Infectious Disease Diagnostic Testing Forecast
10.5.2 South Africa Market Infectious Disease Diagnostic Testing Forecast
10.5.3 Israel Market Infectious Disease Diagnostic Testing Forecast
10.5.4 Turkey Market Infectious Disease Diagnostic Testing Forecast
10.6 Global Infectious Disease Diagnostic Testing Forecast by Type (2027-2032)
10.7 Global Infectious Disease Diagnostic Testing Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Infectious Disease Diagnostic Testing Forecast
11 KEY PLAYERS ANALYSIS
11.1 BD
11.1.1 BD Company Information
11.1.2 BD Infectious Disease Diagnostic Testing Product Offered
11.1.3 BD Infectious Disease Diagnostic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 BD Main Business Overview
11.1.5 BD Latest Developments
11.2 Danaher
11.2.1 Danaher Company Information
11.2.2 Danaher Infectious Disease Diagnostic Testing Product Offered
11.2.3 Danaher Infectious Disease Diagnostic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Danaher Main Business Overview
11.2.5 Danaher Latest Developments
11.3 Abbott
11.3.1 Abbott Company Information
11.3.2 Abbott Infectious Disease Diagnostic Testing Product Offered
11.3.3 Abbott Infectious Disease Diagnostic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Abbott Main Business Overview
11.3.5 Abbott Latest Developments
11.4 bioM?rieux
11.4.1 bioM?rieux Company Information
11.4.2 bioM?rieux Infectious Disease Diagnostic Testing Product Offered
11.4.3 bioM?rieux Infectious Disease Diagnostic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 bioM?rieux Main Business Overview
11.4.5 bioM?rieux Latest Developments
11.5 Hologic
11.5.1 Hologic Company Information
11.5.2 Hologic Infectious Disease Diagnostic Testing Product Offered
11.5.3 Hologic Infectious Disease Diagnostic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Hologic Main Business Overview
11.5.5 Hologic Latest Developments
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Information
11.6.2 Thermo Fisher Scientific Infectious Disease Diagnostic Testing Product Offered
11.6.3 Thermo Fisher Scientific Infectious Disease Diagnostic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Thermo Fisher Scientific Main Business Overview
11.6.5 Thermo Fisher Scientific Latest Developments
11.7 Roche
11.7.1 Roche Company Information
11.7.2 Roche Infectious Disease Diagnostic Testing Product Offered
11.7.3 Roche Infectious Disease Diagnostic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Roche Main Business Overview
11.7.5 Roche Latest Developments
11.8 DiaSorin
11.8.1 DiaSorin Company Information
11.8.2 DiaSorin Infectious Disease Diagnostic Testing Product Offered
11.8.3 DiaSorin Infectious Disease Diagnostic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 DiaSorin Main Business Overview
11.8.5 DiaSorin Latest Developments
11.9 QuidelOrtho
11.9.1 QuidelOrtho Company Information
11.9.2 QuidelOrtho Infectious Disease Diagnostic Testing Product Offered
11.9.3 QuidelOrtho Infectious Disease Diagnostic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 QuidelOrtho Main Business Overview
11.9.5 QuidelOrtho Latest Developments
11.10 Siemens Healthineers
11.10.1 Siemens Healthineers Company Information
11.10.2 Siemens Healthineers Infectious Disease Diagnostic Testing Product Offered
11.10.3 Siemens Healthineers Infectious Disease Diagnostic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Siemens Healthineers Main Business Overview
11.10.5 Siemens Healthineers Latest Developments
11.11 Qiagen
11.11.1 Qiagen Company Information
11.11.2 Qiagen Infectious Disease Diagnostic Testing Product Offered
11.11.3 Qiagen Infectious Disease Diagnostic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Qiagen Main Business Overview
11.11.5 Qiagen Latest Developments
11.12 Bio-Rad
11.12.1 Bio-Rad Company Information
11.12.2 Bio-Rad Infectious Disease Diagnostic Testing Product Offered
11.12.3 Bio-Rad Infectious Disease Diagnostic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Bio-Rad Main Business Overview
11.12.5 Bio-Rad Latest Developments
11.13 Wondfo Biotech
11.13.1 Wondfo Biotech Company Information
11.13.2 Wondfo Biotech Infectious Disease Diagnostic Testing Product Offered
11.13.3 Wondfo Biotech Infectious Disease Diagnostic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Wondfo Biotech Main Business Overview
11.13.5 Wondfo Biotech Latest Developments
11.14 Autobio
11.14.1 Autobio Company Information
11.14.2 Autobio Infectious Disease Diagnostic Testing Product Offered
11.14.3 Autobio Infectious Disease Diagnostic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Autobio Main Business Overview
11.14.5 Autobio Latest Developments
11.15 Daan Gene
11.15.1 Daan Gene Company Information
11.15.2 Daan Gene Infectious Disease Diagnostic Testing Product Offered
11.15.3 Daan Gene Infectious Disease Diagnostic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Daan Gene Main Business Overview
11.15.5 Daan Gene Latest Developments
11.16 Innovita
11.16.1 Innovita Company Information
11.16.2 Innovita Infectious Disease Diagnostic Testing Product Offered
11.16.3 Innovita Infectious Disease Diagnostic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Innovita Main Business Overview
11.16.5 Innovita Latest Developments
11.17 Hybribio
11.17.1 Hybribio Company Information
11.17.2 Hybribio Infectious Disease Diagnostic Testing Product Offered
11.17.3 Hybribio Infectious Disease Diagnostic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Hybribio Main Business Overview
11.17.5 Hybribio Latest Developments
11.18 BioPerfectus
11.18.1 BioPerfectus Company Information
11.18.2 BioPerfectus Infectious Disease Diagnostic Testing Product Offered
11.18.3 BioPerfectus Infectious Disease Diagnostic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 BioPerfectus Main Business Overview
11.18.5 BioPerfectus Latest Developments
11.19 Sansure
11.19.1 Sansure Company Information
11.19.2 Sansure Infectious Disease Diagnostic Testing Product Offered
11.19.3 Sansure Infectious Disease Diagnostic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Sansure Main Business Overview
11.19.5 Sansure Latest Developments
11.20 Liferiver
11.20.1 Liferiver Company Information
11.20.2 Liferiver Infectious Disease Diagnostic Testing Product Offered
11.20.3 Liferiver Infectious Disease Diagnostic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Liferiver Main Business Overview
11.20.5 Liferiver Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Infectious Disease Diagnostic Testing Market Size (2021-2032)
2.1.2 Infectious Disease Diagnostic Testing Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Infectious Disease Diagnostic Testing by Country/Region (2021, 2025 & 2032)
2.2 Infectious Disease Diagnostic Testing Segment by Type
2.2.1 Blood Sample
2.2.2 Respiratory Sample
2.2.3 Urine Sample
2.2.4 Other
2.2.5 Infectious Disease Diagnostic Testing Market Size by Type
2.2.5.1 Infectious Disease Diagnostic Testing Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Infectious Disease Diagnostic Testing Market Size Market Share by Type (2021-2026)
2.3 Infectious Disease Diagnostic Testing Segment by Technology
2.3.1 Molecular Diagnostics
2.3.2 Immunodiagnostics
2.3.3 Culture & AST
2.3.4 POCT Rapid Tests
2.3.5 Other
2.3.6 Infectious Disease Diagnostic Testing Market Size by Technology
2.3.6.1 Infectious Disease Diagnostic Testing Market Size CAGR by Technology (2021 VS 2025 VS 2032)
2.3.6.2 Global Infectious Disease Diagnostic Testing Market Size Market Share by Technology (2021-2026)
2.4 Infectious Disease Diagnostic Testing Segment by Test Item
2.4.1 Respiratory Infections
2.4.2 Hepatitis & Blood-borne
2.4.3 Sexually Transmitted Infections
2.4.4 Gastrointestinal Infections
2.4.5 Other
2.4.6 Infectious Disease Diagnostic Testing Market Size by Test Item
2.4.6.1 Infectious Disease Diagnostic Testing Market Size CAGR by Test Item (2021 VS 2025 VS 2032)
2.4.6.2 Global Infectious Disease Diagnostic Testing Market Size Market Share by Test Item (2021-2026)
2.5 Infectious Disease Diagnostic Testing Segment by Application
2.5.1 Public Hospitals
2.5.2 Third-party Independent Laboratory
2.5.3 Other
2.5.4 Infectious Disease Diagnostic Testing Market Size by Application
2.5.4.1 Infectious Disease Diagnostic Testing Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Infectious Disease Diagnostic Testing Market Size Market Share by Application (2021-2026)
3 INFECTIOUS DISEASE DIAGNOSTIC TESTING MARKET SIZE BY PLAYER
3.1 Infectious Disease Diagnostic Testing Market Size Market Share by Player
3.1.1 Global Infectious Disease Diagnostic Testing Revenue by Player (2021-2026)
3.1.2 Global Infectious Disease Diagnostic Testing Revenue Market Share by Player (2021-2026)
3.2 Global Infectious Disease Diagnostic Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 INFECTIOUS DISEASE DIAGNOSTIC TESTING BY REGION
4.1 Infectious Disease Diagnostic Testing Market Size by Region (2021-2026)
4.2 Global Infectious Disease Diagnostic Testing Annual Revenue by Country/Region (2021-2026)
4.3 Americas Infectious Disease Diagnostic Testing Market Size Growth (2021-2026)
4.4 APAC Infectious Disease Diagnostic Testing Market Size Growth (2021-2026)
4.5 Europe Infectious Disease Diagnostic Testing Market Size Growth (2021-2026)
4.6 Middle East & Africa Infectious Disease Diagnostic Testing Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Infectious Disease Diagnostic Testing Market Size by Country (2021-2026)
5.2 Americas Infectious Disease Diagnostic Testing Market Size by Type (2021-2026)
5.3 Americas Infectious Disease Diagnostic Testing Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Infectious Disease Diagnostic Testing Market Size by Region (2021-2026)
6.2 APAC Infectious Disease Diagnostic Testing Market Size by Type (2021-2026)
6.3 APAC Infectious Disease Diagnostic Testing Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Infectious Disease Diagnostic Testing Market Size by Country (2021-2026)
7.2 Europe Infectious Disease Diagnostic Testing Market Size by Type (2021-2026)
7.3 Europe Infectious Disease Diagnostic Testing Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Infectious Disease Diagnostic Testing by Region (2021-2026)
8.2 Middle East & Africa Infectious Disease Diagnostic Testing Market Size by Type (2021-2026)
8.3 Middle East & Africa Infectious Disease Diagnostic Testing Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL INFECTIOUS DISEASE DIAGNOSTIC TESTING MARKET FORECAST
10.1 Global Infectious Disease Diagnostic Testing Forecast by Region (2027-2032)
10.1.1 Global Infectious Disease Diagnostic Testing Forecast by Region (2027-2032)
10.1.2 Americas Infectious Disease Diagnostic Testing Forecast
10.1.3 APAC Infectious Disease Diagnostic Testing Forecast
10.1.4 Europe Infectious Disease Diagnostic Testing Forecast
10.1.5 Middle East & Africa Infectious Disease Diagnostic Testing Forecast
10.2 Americas Infectious Disease Diagnostic Testing Forecast by Country (2027-2032)
10.2.1 United States Market Infectious Disease Diagnostic Testing Forecast
10.2.2 Canada Market Infectious Disease Diagnostic Testing Forecast
10.2.3 Mexico Market Infectious Disease Diagnostic Testing Forecast
10.2.4 Brazil Market Infectious Disease Diagnostic Testing Forecast
10.3 APAC Infectious Disease Diagnostic Testing Forecast by Region (2027-2032)
10.3.1 China Infectious Disease Diagnostic Testing Market Forecast
10.3.2 Japan Market Infectious Disease Diagnostic Testing Forecast
10.3.3 Korea Market Infectious Disease Diagnostic Testing Forecast
10.3.4 Southeast Asia Market Infectious Disease Diagnostic Testing Forecast
10.3.5 India Market Infectious Disease Diagnostic Testing Forecast
10.3.6 Australia Market Infectious Disease Diagnostic Testing Forecast
10.4 Europe Infectious Disease Diagnostic Testing Forecast by Country (2027-2032)
10.4.1 Germany Market Infectious Disease Diagnostic Testing Forecast
10.4.2 France Market Infectious Disease Diagnostic Testing Forecast
10.4.3 UK Market Infectious Disease Diagnostic Testing Forecast
10.4.4 Italy Market Infectious Disease Diagnostic Testing Forecast
10.4.5 Russia Market Infectious Disease Diagnostic Testing Forecast
10.5 Middle East & Africa Infectious Disease Diagnostic Testing Forecast by Region (2027-2032)
10.5.1 Egypt Market Infectious Disease Diagnostic Testing Forecast
10.5.2 South Africa Market Infectious Disease Diagnostic Testing Forecast
10.5.3 Israel Market Infectious Disease Diagnostic Testing Forecast
10.5.4 Turkey Market Infectious Disease Diagnostic Testing Forecast
10.6 Global Infectious Disease Diagnostic Testing Forecast by Type (2027-2032)
10.7 Global Infectious Disease Diagnostic Testing Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Infectious Disease Diagnostic Testing Forecast
11 KEY PLAYERS ANALYSIS
11.1 BD
11.1.1 BD Company Information
11.1.2 BD Infectious Disease Diagnostic Testing Product Offered
11.1.3 BD Infectious Disease Diagnostic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 BD Main Business Overview
11.1.5 BD Latest Developments
11.2 Danaher
11.2.1 Danaher Company Information
11.2.2 Danaher Infectious Disease Diagnostic Testing Product Offered
11.2.3 Danaher Infectious Disease Diagnostic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Danaher Main Business Overview
11.2.5 Danaher Latest Developments
11.3 Abbott
11.3.1 Abbott Company Information
11.3.2 Abbott Infectious Disease Diagnostic Testing Product Offered
11.3.3 Abbott Infectious Disease Diagnostic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Abbott Main Business Overview
11.3.5 Abbott Latest Developments
11.4 bioM?rieux
11.4.1 bioM?rieux Company Information
11.4.2 bioM?rieux Infectious Disease Diagnostic Testing Product Offered
11.4.3 bioM?rieux Infectious Disease Diagnostic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 bioM?rieux Main Business Overview
11.4.5 bioM?rieux Latest Developments
11.5 Hologic
11.5.1 Hologic Company Information
11.5.2 Hologic Infectious Disease Diagnostic Testing Product Offered
11.5.3 Hologic Infectious Disease Diagnostic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Hologic Main Business Overview
11.5.5 Hologic Latest Developments
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Information
11.6.2 Thermo Fisher Scientific Infectious Disease Diagnostic Testing Product Offered
11.6.3 Thermo Fisher Scientific Infectious Disease Diagnostic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Thermo Fisher Scientific Main Business Overview
11.6.5 Thermo Fisher Scientific Latest Developments
11.7 Roche
11.7.1 Roche Company Information
11.7.2 Roche Infectious Disease Diagnostic Testing Product Offered
11.7.3 Roche Infectious Disease Diagnostic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Roche Main Business Overview
11.7.5 Roche Latest Developments
11.8 DiaSorin
11.8.1 DiaSorin Company Information
11.8.2 DiaSorin Infectious Disease Diagnostic Testing Product Offered
11.8.3 DiaSorin Infectious Disease Diagnostic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 DiaSorin Main Business Overview
11.8.5 DiaSorin Latest Developments
11.9 QuidelOrtho
11.9.1 QuidelOrtho Company Information
11.9.2 QuidelOrtho Infectious Disease Diagnostic Testing Product Offered
11.9.3 QuidelOrtho Infectious Disease Diagnostic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 QuidelOrtho Main Business Overview
11.9.5 QuidelOrtho Latest Developments
11.10 Siemens Healthineers
11.10.1 Siemens Healthineers Company Information
11.10.2 Siemens Healthineers Infectious Disease Diagnostic Testing Product Offered
11.10.3 Siemens Healthineers Infectious Disease Diagnostic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Siemens Healthineers Main Business Overview
11.10.5 Siemens Healthineers Latest Developments
11.11 Qiagen
11.11.1 Qiagen Company Information
11.11.2 Qiagen Infectious Disease Diagnostic Testing Product Offered
11.11.3 Qiagen Infectious Disease Diagnostic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Qiagen Main Business Overview
11.11.5 Qiagen Latest Developments
11.12 Bio-Rad
11.12.1 Bio-Rad Company Information
11.12.2 Bio-Rad Infectious Disease Diagnostic Testing Product Offered
11.12.3 Bio-Rad Infectious Disease Diagnostic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Bio-Rad Main Business Overview
11.12.5 Bio-Rad Latest Developments
11.13 Wondfo Biotech
11.13.1 Wondfo Biotech Company Information
11.13.2 Wondfo Biotech Infectious Disease Diagnostic Testing Product Offered
11.13.3 Wondfo Biotech Infectious Disease Diagnostic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Wondfo Biotech Main Business Overview
11.13.5 Wondfo Biotech Latest Developments
11.14 Autobio
11.14.1 Autobio Company Information
11.14.2 Autobio Infectious Disease Diagnostic Testing Product Offered
11.14.3 Autobio Infectious Disease Diagnostic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Autobio Main Business Overview
11.14.5 Autobio Latest Developments
11.15 Daan Gene
11.15.1 Daan Gene Company Information
11.15.2 Daan Gene Infectious Disease Diagnostic Testing Product Offered
11.15.3 Daan Gene Infectious Disease Diagnostic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Daan Gene Main Business Overview
11.15.5 Daan Gene Latest Developments
11.16 Innovita
11.16.1 Innovita Company Information
11.16.2 Innovita Infectious Disease Diagnostic Testing Product Offered
11.16.3 Innovita Infectious Disease Diagnostic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Innovita Main Business Overview
11.16.5 Innovita Latest Developments
11.17 Hybribio
11.17.1 Hybribio Company Information
11.17.2 Hybribio Infectious Disease Diagnostic Testing Product Offered
11.17.3 Hybribio Infectious Disease Diagnostic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Hybribio Main Business Overview
11.17.5 Hybribio Latest Developments
11.18 BioPerfectus
11.18.1 BioPerfectus Company Information
11.18.2 BioPerfectus Infectious Disease Diagnostic Testing Product Offered
11.18.3 BioPerfectus Infectious Disease Diagnostic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 BioPerfectus Main Business Overview
11.18.5 BioPerfectus Latest Developments
11.19 Sansure
11.19.1 Sansure Company Information
11.19.2 Sansure Infectious Disease Diagnostic Testing Product Offered
11.19.3 Sansure Infectious Disease Diagnostic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Sansure Main Business Overview
11.19.5 Sansure Latest Developments
11.20 Liferiver
11.20.1 Liferiver Company Information
11.20.2 Liferiver Infectious Disease Diagnostic Testing Product Offered
11.20.3 Liferiver Infectious Disease Diagnostic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Liferiver Main Business Overview
11.20.5 Liferiver Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Infectious Disease Diagnostic Testing Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Infectious Disease Diagnostic Testing Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Blood Sample
Table 4. Major Players of Respiratory Sample
Table 5. Major Players of Urine Sample
Table 6. Major Players of Other
Table 7. Infectious Disease Diagnostic Testing Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Infectious Disease Diagnostic Testing Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Infectious Disease Diagnostic Testing Market Size Market Share by Type (2021-2026)
Table 10. Major Players of Molecular Diagnostics
Table 11. Major Players of Immunodiagnostics
Table 12. Major Players of Culture & AST
Table 13. Major Players of POCT Rapid Tests
Table 14. Major Players of Other
Table 15. Infectious Disease Diagnostic Testing Market Size CAGR by Technology (2021 VS 2025 VS 2032) & ($ millions)
Table 16. Global Infectious Disease Diagnostic Testing Market Size by Technology (2021-2026) & ($ millions)
Table 17. Global Infectious Disease Diagnostic Testing Market Size Market Share by Technology (2021-2026)
Table 18. Major Players of Respiratory Infections
Table 19. Major Players of Hepatitis & Blood-borne
Table 20. Major Players of Sexually Transmitted Infections
Table 21. Major Players of Gastrointestinal Infections
Table 22. Major Players of Other
Table 23. Infectious Disease Diagnostic Testing Market Size CAGR by Test Item (2021 VS 2025 VS 2032) & ($ millions)
Table 24. Global Infectious Disease Diagnostic Testing Market Size by Test Item (2021-2026) & ($ millions)
Table 25. Global Infectious Disease Diagnostic Testing Market Size Market Share by Test Item (2021-2026)
Table 26. Infectious Disease Diagnostic Testing Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 27. Global Infectious Disease Diagnostic Testing Market Size by Application (2021-2026) & ($ millions)
Table 28. Global Infectious Disease Diagnostic Testing Market Size Market Share by Application (2021-2026)
Table 29. Global Infectious Disease Diagnostic Testing Revenue by Player (2021-2026) & ($ millions)
Table 30. Global Infectious Disease Diagnostic Testing Revenue Market Share by Player (2021-2026)
Table 31. Infectious Disease Diagnostic Testing Key Players Head office and Products Offered
Table 32. Infectious Disease Diagnostic Testing Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 33. New Products and Potential Entrants
Table 34. Mergers & Acquisitions, Expansion
Table 35. Global Infectious Disease Diagnostic Testing Market Size by Region (2021-2026) & ($ millions)
Table 36. Global Infectious Disease Diagnostic Testing Market Size Market Share by Region (2021-2026)
Table 37. Global Infectious Disease Diagnostic Testing Revenue by Country/Region (2021-2026) & ($ millions)
Table 38. Global Infectious Disease Diagnostic Testing Revenue Market Share by Country/Region (2021-2026)
Table 39. Americas Infectious Disease Diagnostic Testing Market Size by Country (2021-2026) & ($ millions)
Table 40. Americas Infectious Disease Diagnostic Testing Market Size Market Share by Country (2021-2026)
Table 41. Americas Infectious Disease Diagnostic Testing Market Size by Type (2021-2026) & ($ millions)
Table 42. Americas Infectious Disease Diagnostic Testing Market Size Market Share by Type (2021-2026)
Table 43. Americas Infectious Disease Diagnostic Testing Market Size by Application (2021-2026) & ($ millions)
Table 44. Americas Infectious Disease Diagnostic Testing Market Size Market Share by Application (2021-2026)
Table 45. APAC Infectious Disease Diagnostic Testing Market Size by Region (2021-2026) & ($ millions)
Table 46. APAC Infectious Disease Diagnostic Testing Market Size Market Share by Region (2021-2026)
Table 47. APAC Infectious Disease Diagnostic Testing Market Size by Type (2021-2026) & ($ millions)
Table 48. APAC Infectious Disease Diagnostic Testing Market Size by Application (2021-2026) & ($ millions)
Table 49. Europe Infectious Disease Diagnostic Testing Market Size by Country (2021-2026) & ($ millions)
Table 50. Europe Infectious Disease Diagnostic Testing Market Size Market Share by Country (2021-2026)
Table 51. Europe Infectious Disease Diagnostic Testing Market Size by Type (2021-2026) & ($ millions)
Table 52. Europe Infectious Disease Diagnostic Testing Market Size by Application (2021-2026) & ($ millions)
Table 53. Middle East & Africa Infectious Disease Diagnostic Testing Market Size by Region (2021-2026) & ($ millions)
Table 54. Middle East & Africa Infectious Disease Diagnostic Testing Market Size by Type (2021-2026) & ($ millions)
Table 55. Middle East & Africa Infectious Disease Diagnostic Testing Market Size by Application (2021-2026) & ($ millions)
Table 56. Key Market Drivers & Growth Opportunities of Infectious Disease Diagnostic Testing
Table 57. Key Market Challenges & Risks of Infectious Disease Diagnostic Testing
Table 58. Key Industry Trends of Infectious Disease Diagnostic Testing
Table 59. Global Infectious Disease Diagnostic Testing Market Size Forecast by Region (2027-2032) & ($ millions)
Table 60. Global Infectious Disease Diagnostic Testing Market Size Market Share Forecast by Region (2027-2032)
Table 61. Global Infectious Disease Diagnostic Testing Market Size Forecast by Type (2027-2032) & ($ millions)
Table 62. Global Infectious Disease Diagnostic Testing Market Size Forecast by Application (2027-2032) & ($ millions)
Table 63. BD Details, Company Type, Infectious Disease Diagnostic Testing Area Served and Its Competitors
Table 64. BD Infectious Disease Diagnostic Testing Product Offered
Table 65. BD Infectious Disease Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. BD Main Business
Table 67. BD Latest Developments
Table 68. Danaher Details, Company Type, Infectious Disease Diagnostic Testing Area Served and Its Competitors
Table 69. Danaher Infectious Disease Diagnostic Testing Product Offered
Table 70. Danaher Infectious Disease Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Danaher Main Business
Table 72. Danaher Latest Developments
Table 73. Abbott Details, Company Type, Infectious Disease Diagnostic Testing Area Served and Its Competitors
Table 74. Abbott Infectious Disease Diagnostic Testing Product Offered
Table 75. Abbott Infectious Disease Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Abbott Main Business
Table 77. Abbott Latest Developments
Table 78. bioM?rieux Details, Company Type, Infectious Disease Diagnostic Testing Area Served and Its Competitors
Table 79. bioM?rieux Infectious Disease Diagnostic Testing Product Offered
Table 80. bioM?rieux Infectious Disease Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. bioM?rieux Main Business
Table 82. bioM?rieux Latest Developments
Table 83. Hologic Details, Company Type, Infectious Disease Diagnostic Testing Area Served and Its Competitors
Table 84. Hologic Infectious Disease Diagnostic Testing Product Offered
Table 85. Hologic Infectious Disease Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Hologic Main Business
Table 87. Hologic Latest Developments
Table 88. Thermo Fisher Scientific Details, Company Type, Infectious Disease Diagnostic Testing Area Served and Its Competitors
Table 89. Thermo Fisher Scientific Infectious Disease Diagnostic Testing Product Offered
Table 90. Thermo Fisher Scientific Infectious Disease Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Thermo Fisher Scientific Main Business
Table 92. Thermo Fisher Scientific Latest Developments
Table 93. Roche Details, Company Type, Infectious Disease Diagnostic Testing Area Served and Its Competitors
Table 94. Roche Infectious Disease Diagnostic Testing Product Offered
Table 95. Roche Infectious Disease Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Roche Main Business
Table 97. Roche Latest Developments
Table 98. DiaSorin Details, Company Type, Infectious Disease Diagnostic Testing Area Served and Its Competitors
Table 99. DiaSorin Infectious Disease Diagnostic Testing Product Offered
Table 100. DiaSorin Infectious Disease Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. DiaSorin Main Business
Table 102. DiaSorin Latest Developments
Table 103. QuidelOrtho Details, Company Type, Infectious Disease Diagnostic Testing Area Served and Its Competitors
Table 104. QuidelOrtho Infectious Disease Diagnostic Testing Product Offered
Table 105. QuidelOrtho Infectious Disease Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. QuidelOrtho Main Business
Table 107. QuidelOrtho Latest Developments
Table 108. Siemens Healthineers Details, Company Type, Infectious Disease Diagnostic Testing Area Served and Its Competitors
Table 109. Siemens Healthineers Infectious Disease Diagnostic Testing Product Offered
Table 110. Siemens Healthineers Infectious Disease Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 111. Siemens Healthineers Main Business
Table 112. Siemens Healthineers Latest Developments
Table 113. Qiagen Details, Company Type, Infectious Disease Diagnostic Testing Area Served and Its Competitors
Table 114. Qiagen Infectious Disease Diagnostic Testing Product Offered
Table 115. Qiagen Infectious Disease Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 116. Qiagen Main Business
Table 117. Qiagen Latest Developments
Table 118. Bio-Rad Details, Company Type, Infectious Disease Diagnostic Testing Area Served and Its Competitors
Table 119. Bio-Rad Infectious Disease Diagnostic Testing Product Offered
Table 120. Bio-Rad Infectious Disease Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 121. Bio-Rad Main Business
Table 122. Bio-Rad Latest Developments
Table 123. Wondfo Biotech Details, Company Type, Infectious Disease Diagnostic Testing Area Served and Its Competitors
Table 124. Wondfo Biotech Infectious Disease Diagnostic Testing Product Offered
Table 125. Wondfo Biotech Infectious Disease Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 126. Wondfo Biotech Main Business
Table 127. Wondfo Biotech Latest Developments
Table 128. Autobio Details, Company Type, Infectious Disease Diagnostic Testing Area Served and Its Competitors
Table 129. Autobio Infectious Disease Diagnostic Testing Product Offered
Table 130. Autobio Infectious Disease Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 131. Autobio Main Business
Table 132. Autobio Latest Developments
Table 133. Daan Gene Details, Company Type, Infectious Disease Diagnostic Testing Area Served and Its Competitors
Table 134. Daan Gene Infectious Disease Diagnostic Testing Product Offered
Table 135. Daan Gene Infectious Disease Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 136. Daan Gene Main Business
Table 137. Daan Gene Latest Developments
Table 138. Innovita Details, Company Type, Infectious Disease Diagnostic Testing Area Served and Its Competitors
Table 139. Innovita Infectious Disease Diagnostic Testing Product Offered
Table 140. Innovita Infectious Disease Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 141. Innovita Main Business
Table 142. Innovita Latest Developments
Table 143. Hybribio Details, Company Type, Infectious Disease Diagnostic Testing Area Served and Its Competitors
Table 144. Hybribio Infectious Disease Diagnostic Testing Product Offered
Table 145. Hybribio Infectious Disease Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 146. Hybribio Main Business
Table 147. Hybribio Latest Developments
Table 148. BioPerfectus Details, Company Type, Infectious Disease Diagnostic Testing Area Served and Its Competitors
Table 149. BioPerfectus Infectious Disease Diagnostic Testing Product Offered
Table 150. BioPerfectus Infectious Disease Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 151. BioPerfectus Main Business
Table 152. BioPerfectus Latest Developments
Table 153. Sansure Details, Company Type, Infectious Disease Diagnostic Testing Area Served and Its Competitors
Table 154. Sansure Infectious Disease Diagnostic Testing Product Offered
Table 155. Sansure Infectious Disease Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 156. Sansure Main Business
Table 157. Sansure Latest Developments
Table 158. Liferiver Details, Company Type, Infectious Disease Diagnostic Testing Area Served and Its Competitors
Table 159. Liferiver Infectious Disease Diagnostic Testing Product Offered
Table 160. Liferiver Infectious Disease Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 161. Liferiver Main Business
Table 162. Liferiver Latest Developments
Table 1. Infectious Disease Diagnostic Testing Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Infectious Disease Diagnostic Testing Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Blood Sample
Table 4. Major Players of Respiratory Sample
Table 5. Major Players of Urine Sample
Table 6. Major Players of Other
Table 7. Infectious Disease Diagnostic Testing Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Infectious Disease Diagnostic Testing Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Infectious Disease Diagnostic Testing Market Size Market Share by Type (2021-2026)
Table 10. Major Players of Molecular Diagnostics
Table 11. Major Players of Immunodiagnostics
Table 12. Major Players of Culture & AST
Table 13. Major Players of POCT Rapid Tests
Table 14. Major Players of Other
Table 15. Infectious Disease Diagnostic Testing Market Size CAGR by Technology (2021 VS 2025 VS 2032) & ($ millions)
Table 16. Global Infectious Disease Diagnostic Testing Market Size by Technology (2021-2026) & ($ millions)
Table 17. Global Infectious Disease Diagnostic Testing Market Size Market Share by Technology (2021-2026)
Table 18. Major Players of Respiratory Infections
Table 19. Major Players of Hepatitis & Blood-borne
Table 20. Major Players of Sexually Transmitted Infections
Table 21. Major Players of Gastrointestinal Infections
Table 22. Major Players of Other
Table 23. Infectious Disease Diagnostic Testing Market Size CAGR by Test Item (2021 VS 2025 VS 2032) & ($ millions)
Table 24. Global Infectious Disease Diagnostic Testing Market Size by Test Item (2021-2026) & ($ millions)
Table 25. Global Infectious Disease Diagnostic Testing Market Size Market Share by Test Item (2021-2026)
Table 26. Infectious Disease Diagnostic Testing Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 27. Global Infectious Disease Diagnostic Testing Market Size by Application (2021-2026) & ($ millions)
Table 28. Global Infectious Disease Diagnostic Testing Market Size Market Share by Application (2021-2026)
Table 29. Global Infectious Disease Diagnostic Testing Revenue by Player (2021-2026) & ($ millions)
Table 30. Global Infectious Disease Diagnostic Testing Revenue Market Share by Player (2021-2026)
Table 31. Infectious Disease Diagnostic Testing Key Players Head office and Products Offered
Table 32. Infectious Disease Diagnostic Testing Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 33. New Products and Potential Entrants
Table 34. Mergers & Acquisitions, Expansion
Table 35. Global Infectious Disease Diagnostic Testing Market Size by Region (2021-2026) & ($ millions)
Table 36. Global Infectious Disease Diagnostic Testing Market Size Market Share by Region (2021-2026)
Table 37. Global Infectious Disease Diagnostic Testing Revenue by Country/Region (2021-2026) & ($ millions)
Table 38. Global Infectious Disease Diagnostic Testing Revenue Market Share by Country/Region (2021-2026)
Table 39. Americas Infectious Disease Diagnostic Testing Market Size by Country (2021-2026) & ($ millions)
Table 40. Americas Infectious Disease Diagnostic Testing Market Size Market Share by Country (2021-2026)
Table 41. Americas Infectious Disease Diagnostic Testing Market Size by Type (2021-2026) & ($ millions)
Table 42. Americas Infectious Disease Diagnostic Testing Market Size Market Share by Type (2021-2026)
Table 43. Americas Infectious Disease Diagnostic Testing Market Size by Application (2021-2026) & ($ millions)
Table 44. Americas Infectious Disease Diagnostic Testing Market Size Market Share by Application (2021-2026)
Table 45. APAC Infectious Disease Diagnostic Testing Market Size by Region (2021-2026) & ($ millions)
Table 46. APAC Infectious Disease Diagnostic Testing Market Size Market Share by Region (2021-2026)
Table 47. APAC Infectious Disease Diagnostic Testing Market Size by Type (2021-2026) & ($ millions)
Table 48. APAC Infectious Disease Diagnostic Testing Market Size by Application (2021-2026) & ($ millions)
Table 49. Europe Infectious Disease Diagnostic Testing Market Size by Country (2021-2026) & ($ millions)
Table 50. Europe Infectious Disease Diagnostic Testing Market Size Market Share by Country (2021-2026)
Table 51. Europe Infectious Disease Diagnostic Testing Market Size by Type (2021-2026) & ($ millions)
Table 52. Europe Infectious Disease Diagnostic Testing Market Size by Application (2021-2026) & ($ millions)
Table 53. Middle East & Africa Infectious Disease Diagnostic Testing Market Size by Region (2021-2026) & ($ millions)
Table 54. Middle East & Africa Infectious Disease Diagnostic Testing Market Size by Type (2021-2026) & ($ millions)
Table 55. Middle East & Africa Infectious Disease Diagnostic Testing Market Size by Application (2021-2026) & ($ millions)
Table 56. Key Market Drivers & Growth Opportunities of Infectious Disease Diagnostic Testing
Table 57. Key Market Challenges & Risks of Infectious Disease Diagnostic Testing
Table 58. Key Industry Trends of Infectious Disease Diagnostic Testing
Table 59. Global Infectious Disease Diagnostic Testing Market Size Forecast by Region (2027-2032) & ($ millions)
Table 60. Global Infectious Disease Diagnostic Testing Market Size Market Share Forecast by Region (2027-2032)
Table 61. Global Infectious Disease Diagnostic Testing Market Size Forecast by Type (2027-2032) & ($ millions)
Table 62. Global Infectious Disease Diagnostic Testing Market Size Forecast by Application (2027-2032) & ($ millions)
Table 63. BD Details, Company Type, Infectious Disease Diagnostic Testing Area Served and Its Competitors
Table 64. BD Infectious Disease Diagnostic Testing Product Offered
Table 65. BD Infectious Disease Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. BD Main Business
Table 67. BD Latest Developments
Table 68. Danaher Details, Company Type, Infectious Disease Diagnostic Testing Area Served and Its Competitors
Table 69. Danaher Infectious Disease Diagnostic Testing Product Offered
Table 70. Danaher Infectious Disease Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Danaher Main Business
Table 72. Danaher Latest Developments
Table 73. Abbott Details, Company Type, Infectious Disease Diagnostic Testing Area Served and Its Competitors
Table 74. Abbott Infectious Disease Diagnostic Testing Product Offered
Table 75. Abbott Infectious Disease Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Abbott Main Business
Table 77. Abbott Latest Developments
Table 78. bioM?rieux Details, Company Type, Infectious Disease Diagnostic Testing Area Served and Its Competitors
Table 79. bioM?rieux Infectious Disease Diagnostic Testing Product Offered
Table 80. bioM?rieux Infectious Disease Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. bioM?rieux Main Business
Table 82. bioM?rieux Latest Developments
Table 83. Hologic Details, Company Type, Infectious Disease Diagnostic Testing Area Served and Its Competitors
Table 84. Hologic Infectious Disease Diagnostic Testing Product Offered
Table 85. Hologic Infectious Disease Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Hologic Main Business
Table 87. Hologic Latest Developments
Table 88. Thermo Fisher Scientific Details, Company Type, Infectious Disease Diagnostic Testing Area Served and Its Competitors
Table 89. Thermo Fisher Scientific Infectious Disease Diagnostic Testing Product Offered
Table 90. Thermo Fisher Scientific Infectious Disease Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Thermo Fisher Scientific Main Business
Table 92. Thermo Fisher Scientific Latest Developments
Table 93. Roche Details, Company Type, Infectious Disease Diagnostic Testing Area Served and Its Competitors
Table 94. Roche Infectious Disease Diagnostic Testing Product Offered
Table 95. Roche Infectious Disease Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Roche Main Business
Table 97. Roche Latest Developments
Table 98. DiaSorin Details, Company Type, Infectious Disease Diagnostic Testing Area Served and Its Competitors
Table 99. DiaSorin Infectious Disease Diagnostic Testing Product Offered
Table 100. DiaSorin Infectious Disease Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. DiaSorin Main Business
Table 102. DiaSorin Latest Developments
Table 103. QuidelOrtho Details, Company Type, Infectious Disease Diagnostic Testing Area Served and Its Competitors
Table 104. QuidelOrtho Infectious Disease Diagnostic Testing Product Offered
Table 105. QuidelOrtho Infectious Disease Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. QuidelOrtho Main Business
Table 107. QuidelOrtho Latest Developments
Table 108. Siemens Healthineers Details, Company Type, Infectious Disease Diagnostic Testing Area Served and Its Competitors
Table 109. Siemens Healthineers Infectious Disease Diagnostic Testing Product Offered
Table 110. Siemens Healthineers Infectious Disease Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 111. Siemens Healthineers Main Business
Table 112. Siemens Healthineers Latest Developments
Table 113. Qiagen Details, Company Type, Infectious Disease Diagnostic Testing Area Served and Its Competitors
Table 114. Qiagen Infectious Disease Diagnostic Testing Product Offered
Table 115. Qiagen Infectious Disease Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 116. Qiagen Main Business
Table 117. Qiagen Latest Developments
Table 118. Bio-Rad Details, Company Type, Infectious Disease Diagnostic Testing Area Served and Its Competitors
Table 119. Bio-Rad Infectious Disease Diagnostic Testing Product Offered
Table 120. Bio-Rad Infectious Disease Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 121. Bio-Rad Main Business
Table 122. Bio-Rad Latest Developments
Table 123. Wondfo Biotech Details, Company Type, Infectious Disease Diagnostic Testing Area Served and Its Competitors
Table 124. Wondfo Biotech Infectious Disease Diagnostic Testing Product Offered
Table 125. Wondfo Biotech Infectious Disease Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 126. Wondfo Biotech Main Business
Table 127. Wondfo Biotech Latest Developments
Table 128. Autobio Details, Company Type, Infectious Disease Diagnostic Testing Area Served and Its Competitors
Table 129. Autobio Infectious Disease Diagnostic Testing Product Offered
Table 130. Autobio Infectious Disease Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 131. Autobio Main Business
Table 132. Autobio Latest Developments
Table 133. Daan Gene Details, Company Type, Infectious Disease Diagnostic Testing Area Served and Its Competitors
Table 134. Daan Gene Infectious Disease Diagnostic Testing Product Offered
Table 135. Daan Gene Infectious Disease Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 136. Daan Gene Main Business
Table 137. Daan Gene Latest Developments
Table 138. Innovita Details, Company Type, Infectious Disease Diagnostic Testing Area Served and Its Competitors
Table 139. Innovita Infectious Disease Diagnostic Testing Product Offered
Table 140. Innovita Infectious Disease Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 141. Innovita Main Business
Table 142. Innovita Latest Developments
Table 143. Hybribio Details, Company Type, Infectious Disease Diagnostic Testing Area Served and Its Competitors
Table 144. Hybribio Infectious Disease Diagnostic Testing Product Offered
Table 145. Hybribio Infectious Disease Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 146. Hybribio Main Business
Table 147. Hybribio Latest Developments
Table 148. BioPerfectus Details, Company Type, Infectious Disease Diagnostic Testing Area Served and Its Competitors
Table 149. BioPerfectus Infectious Disease Diagnostic Testing Product Offered
Table 150. BioPerfectus Infectious Disease Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 151. BioPerfectus Main Business
Table 152. BioPerfectus Latest Developments
Table 153. Sansure Details, Company Type, Infectious Disease Diagnostic Testing Area Served and Its Competitors
Table 154. Sansure Infectious Disease Diagnostic Testing Product Offered
Table 155. Sansure Infectious Disease Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 156. Sansure Main Business
Table 157. Sansure Latest Developments
Table 158. Liferiver Details, Company Type, Infectious Disease Diagnostic Testing Area Served and Its Competitors
Table 159. Liferiver Infectious Disease Diagnostic Testing Product Offered
Table 160. Liferiver Infectious Disease Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 161. Liferiver Main Business
Table 162. Liferiver Latest Developments
LIST OF FIGURES
Figure 1. Infectious Disease Diagnostic Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Infectious Disease Diagnostic Testing Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Infectious Disease Diagnostic Testing Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Infectious Disease Diagnostic Testing Sales Market Share by Country/Region (2025)
Figure 8. Infectious Disease Diagnostic Testing Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Infectious Disease Diagnostic Testing Market Size Market Share by Type in 2025
Figure 10. Global Infectious Disease Diagnostic Testing Market Size Market Share by Technology in 2025
Figure 11. Global Infectious Disease Diagnostic Testing Market Size Market Share by Test Item in 2025
Figure 12. Infectious Disease Diagnostic Testing in Public Hospitals
Figure 13. Global Infectious Disease Diagnostic Testing Market: Public Hospitals (2021-2026) & ($ millions)
Figure 14. Infectious Disease Diagnostic Testing in Third-party Independent Laboratory
Figure 15. Global Infectious Disease Diagnostic Testing Market: Third-party Independent Laboratory (2021-2026) & ($ millions)
Figure 16. Infectious Disease Diagnostic Testing in Other
Figure 17. Global Infectious Disease Diagnostic Testing Market: Other (2021-2026) & ($ millions)
Figure 18. Global Infectious Disease Diagnostic Testing Market Size Market Share by Application in 2025
Figure 19. Global Infectious Disease Diagnostic Testing Revenue Market Share by Player in 2025
Figure 20. Global Infectious Disease Diagnostic Testing Market Size Market Share by Region (2021-2026)
Figure 21. Americas Infectious Disease Diagnostic Testing Market Size 2021-2026 ($ millions)
Figure 22. APAC Infectious Disease Diagnostic Testing Market Size 2021-2026 ($ millions)
Figure 23. Europe Infectious Disease Diagnostic Testing Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Infectious Disease Diagnostic Testing Market Size 2021-2026 ($ millions)
Figure 25. Americas Infectious Disease Diagnostic Testing Value Market Share by Country in 2025
Figure 26. United States Infectious Disease Diagnostic Testing Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Infectious Disease Diagnostic Testing Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Infectious Disease Diagnostic Testing Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Infectious Disease Diagnostic Testing Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Infectious Disease Diagnostic Testing Market Size Market Share by Region in 2025
Figure 31. APAC Infectious Disease Diagnostic Testing Market Size Market Share by Type (2021-2026)
Figure 32. APAC Infectious Disease Diagnostic Testing Market Size Market Share by Application (2021-2026)
Figure 33. China Infectious Disease Diagnostic Testing Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Infectious Disease Diagnostic Testing Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Infectious Disease Diagnostic Testing Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Infectious Disease Diagnostic Testing Market Size Growth 2021-2026 ($ millions)
Figure 37. India Infectious Disease Diagnostic Testing Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Infectious Disease Diagnostic Testing Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Infectious Disease Diagnostic Testing Market Size Market Share by Country in 2025
Figure 40. Europe Infectious Disease Diagnostic Testing Market Size Market Share by Type (2021-2026)
Figure 41. Europe Infectious Disease Diagnostic Testing Market Size Market Share by Application (2021-2026)
Figure 42. Germany Infectious Disease Diagnostic Testing Market Size Growth 2021-2026 ($ millions)
Figure 43. France Infectious Disease Diagnostic Testing Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Infectious Disease Diagnostic Testing Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Infectious Disease Diagnostic Testing Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Infectious Disease Diagnostic Testing Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Infectious Disease Diagnostic Testing Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Infectious Disease Diagnostic Testing Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Infectious Disease Diagnostic Testing Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Infectious Disease Diagnostic Testing Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Infectious Disease Diagnostic Testing Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Infectious Disease Diagnostic Testing Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Infectious Disease Diagnostic Testing Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Infectious Disease Diagnostic Testing Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 56. APAC Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 57. Europe Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 59. United States Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 60. Canada Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 61. Mexico Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 62. Brazil Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 63. China Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 64. Japan Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 65. Korea Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 67. India Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 68. Australia Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 69. Germany Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 70. France Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 71. UK Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 72. Italy Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 73. Russia Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 74. Egypt Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 75. South Africa Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 76. Israel Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 77. Turkey Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 78. Global Infectious Disease Diagnostic Testing Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Infectious Disease Diagnostic Testing Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 1. Infectious Disease Diagnostic Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Infectious Disease Diagnostic Testing Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Infectious Disease Diagnostic Testing Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Infectious Disease Diagnostic Testing Sales Market Share by Country/Region (2025)
Figure 8. Infectious Disease Diagnostic Testing Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Infectious Disease Diagnostic Testing Market Size Market Share by Type in 2025
Figure 10. Global Infectious Disease Diagnostic Testing Market Size Market Share by Technology in 2025
Figure 11. Global Infectious Disease Diagnostic Testing Market Size Market Share by Test Item in 2025
Figure 12. Infectious Disease Diagnostic Testing in Public Hospitals
Figure 13. Global Infectious Disease Diagnostic Testing Market: Public Hospitals (2021-2026) & ($ millions)
Figure 14. Infectious Disease Diagnostic Testing in Third-party Independent Laboratory
Figure 15. Global Infectious Disease Diagnostic Testing Market: Third-party Independent Laboratory (2021-2026) & ($ millions)
Figure 16. Infectious Disease Diagnostic Testing in Other
Figure 17. Global Infectious Disease Diagnostic Testing Market: Other (2021-2026) & ($ millions)
Figure 18. Global Infectious Disease Diagnostic Testing Market Size Market Share by Application in 2025
Figure 19. Global Infectious Disease Diagnostic Testing Revenue Market Share by Player in 2025
Figure 20. Global Infectious Disease Diagnostic Testing Market Size Market Share by Region (2021-2026)
Figure 21. Americas Infectious Disease Diagnostic Testing Market Size 2021-2026 ($ millions)
Figure 22. APAC Infectious Disease Diagnostic Testing Market Size 2021-2026 ($ millions)
Figure 23. Europe Infectious Disease Diagnostic Testing Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Infectious Disease Diagnostic Testing Market Size 2021-2026 ($ millions)
Figure 25. Americas Infectious Disease Diagnostic Testing Value Market Share by Country in 2025
Figure 26. United States Infectious Disease Diagnostic Testing Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Infectious Disease Diagnostic Testing Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Infectious Disease Diagnostic Testing Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Infectious Disease Diagnostic Testing Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Infectious Disease Diagnostic Testing Market Size Market Share by Region in 2025
Figure 31. APAC Infectious Disease Diagnostic Testing Market Size Market Share by Type (2021-2026)
Figure 32. APAC Infectious Disease Diagnostic Testing Market Size Market Share by Application (2021-2026)
Figure 33. China Infectious Disease Diagnostic Testing Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Infectious Disease Diagnostic Testing Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Infectious Disease Diagnostic Testing Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Infectious Disease Diagnostic Testing Market Size Growth 2021-2026 ($ millions)
Figure 37. India Infectious Disease Diagnostic Testing Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Infectious Disease Diagnostic Testing Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Infectious Disease Diagnostic Testing Market Size Market Share by Country in 2025
Figure 40. Europe Infectious Disease Diagnostic Testing Market Size Market Share by Type (2021-2026)
Figure 41. Europe Infectious Disease Diagnostic Testing Market Size Market Share by Application (2021-2026)
Figure 42. Germany Infectious Disease Diagnostic Testing Market Size Growth 2021-2026 ($ millions)
Figure 43. France Infectious Disease Diagnostic Testing Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Infectious Disease Diagnostic Testing Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Infectious Disease Diagnostic Testing Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Infectious Disease Diagnostic Testing Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Infectious Disease Diagnostic Testing Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Infectious Disease Diagnostic Testing Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Infectious Disease Diagnostic Testing Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Infectious Disease Diagnostic Testing Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Infectious Disease Diagnostic Testing Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Infectious Disease Diagnostic Testing Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Infectious Disease Diagnostic Testing Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Infectious Disease Diagnostic Testing Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 56. APAC Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 57. Europe Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 59. United States Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 60. Canada Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 61. Mexico Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 62. Brazil Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 63. China Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 64. Japan Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 65. Korea Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 67. India Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 68. Australia Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 69. Germany Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 70. France Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 71. UK Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 72. Italy Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 73. Russia Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 74. Egypt Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 75. South Africa Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 76. Israel Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 77. Turkey Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
Figure 78. Global Infectious Disease Diagnostic Testing Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Infectious Disease Diagnostic Testing Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Infectious Disease Diagnostic Testing Market Size 2027-2032 ($ millions)
